Washington, DC, April 05, 2023 (GLOBE NEWSWIRE) — Zion Market Research has published a new research report titled “Newcastle Disease Vaccine Market By Vaccine Type (Live Attenuated, Inactivated, Thermostable), By Species (Chicken, Duck, Goose, And Others), And By Region: Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts, 2023 – 2030” in its research database.
“According to the latest research study, the demand of global Newcastle Disease Vaccine Market size & share in terms of revenue was valued at USD 343.9 million in 2022 and it is expected to surpass around USD 462.6 million mark by 2030, growing at a compound annual growth rate (CAGR) of approximately 4.30% during the forecast period 2023 to 2030.”
What is Newcastle Disease Vaccine? How big is the Newcastle Disease Vaccine Industry?
Report Overview:
The global Newcastle disease vaccine market size was worth around USD 343.9 Million in 2022 and is expected to reach USD 462.6 Million by 2030, growing at a compound annual growth rate (CAGR) of 4.3% during the forecast period.
Newcastle Disease Vaccine is a preventative measure used to control the spread of the highly contagious Newcastle disease in poultry. The disease is caused by a paramyxovirus and affects a wide range of domestic and wild bird species, including chickens, turkeys, pigeons, and ducks. The vaccine is formulated to protect against several strains of the Newcastle disease virus. Newcastle Disease Vaccine is administered to chicks and birds through injection or drinking water, and it is effective in preventing the spread of the disease. The vaccine is developed using different methods, including live attenuated, inactivated, and recombinant vaccines, with each type having its advantages and disadvantages.
The use of the Newcastle Disease Vaccine has become an essential practice in the poultry industry worldwide, helping to prevent economic losses due to the high mortality rates caused by the disease. The vaccine has also been a significant contributor to food security, ensuring that safe and healthy poultry products are available to consumers.
Get a Free Sample PDF of this Research Report for more Insights with a Table of Content, Research Methodology, and Graphs – https://www.zionmarketresearch.com/sample/newcastle-disease-vaccine-market
(A free sample of this report is available upon request; please contact us for more information.)
Our Free Sample Report Consists of the Following:
- Introduction, Overview, and in-depth industry analysis are all included in the 2023 updated report.
- The COVID-19 Pandemic Outbreak Impact Analysis is included in the package
- About 220+ Pages Research Report (Including Recent Research)
- Provide detailed chapter-by-chapter guidance on Request
- Updated Regional Analysis with Graphical Representation of Size, Share, and Trends for the Year 2023
- Includes Tables and figures have been updated
- The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis
- Zion Market Research research methodology
(Please note that the sample of this report has been modified to include the COVID-19 impact study prior to delivery.)
Global Newcastle Disease Vaccine Market: Growth Factors
The global Newcastle Disease Vaccine market is driven by factors such as the increasing demand for poultry products, government support for animal health research, and growing awareness among farmers about the benefits of vaccination programs. The market growth is, however, restrained by factors such as the high cost of vaccines, inadequate diagnostic facilities, and the emergence of new strains of the Newcastle disease virus. Nonetheless, opportunities in the market include technological advancements in vaccine production, rising investments in animal health research, and expanding poultry industries in emerging economies. The market players are focusing on developing advanced vaccines, expanding their product portfolios, and collaborating with research institutes and other stakeholders to gain a competitive edge. These factors create ample opportunities for the growth of the market during the forecast period.
Directly Purchase a copy of the report with TOC @ https://www.zionmarketresearch.com/buynow/su/newcastle-disease-vaccine-market
Report Scope
Report Attribute | Details |
Market Size in 2022 | USD 343.9 million |
Projected Market Size in 2030 | USD 462.6 million |
CAGR Growth Rate | 4.30% CAGR |
Base Year | 2022 |
Forecast Years | 2023-2030 |
Key Market Players | Merial, QYH Biotech, CEVA, Yebio, Ringpu (Tianjin) Bio-Pharmacy Co., Ltd, Bayer AG, Hipra, Anicon Labor GmbH, Chengdu Tech-bank Biological Products Co., Ltd., Ringpu Bio-Technology Co., Ltd., MSD Animal Health, Nisseiken Co., Harbin Veterinary Research Institute, Merck Animal Health, ChengDu Tecbond, DHN, Zoetis, Elanco (Lohmann), CAVAC, Vaksindo, FATRO, and others. |
Key Segment | By Vaccine Type, By Species, And By Region |
Major Regions Covered | North America, Europe, Asia Pacific, Latin America, and the Middle East &, Africa |
Purchase Options | Request customized purchase options to meet your research needs. Explore purchase options |
Newcastle Disease Vaccine Market: Segmentation Analysis
The global Newcastle disease vaccine market is segmented based on vaccine type, species, and region.
Based on vaccine type, the market is bifurcated into Live Attenuated, Inactivated, and Thermostable. The live attenuated vaccine segment held the largest market share in 2022 and is further predicted to cite the fastest CAGR during the forecast period. Live Attenuated Vaccines (LAV) have been widely used and preferred over other vaccine types due to their effectiveness, low cost, and ability to provide long-lasting immunity. LAVs have been shown to confer broad-spectrum immunity against different strains of Newcastle disease viruses, making them a popular choice among poultry farmers. These factors will drive the growth of the segment during the forecast period.
Based on species, the market is segmented based on chicken, duck, goose, and others. The chicken segment held the dominating market share in 2022 and is further expected to occupy a significant CAGR during the forecast period. Newcastle Disease Virus (NDV) is a significant threat to the chicken industry, leading to significant economic losses due to high mortality rates and reduced egg production. Therefore, the demand for Newcastle Disease Vaccines is high among chicken farmers, making this segment the most profitable in the market. However, vaccines for other bird species such as ducks and geese are also in demand, especially in regions where these birds are raised commercially or for domestic purposes.
The global Newcastle Disease Vaccine market is segmented as follows:
By Vaccine Type
- Live Attenuated
- Inactivated
- Thermostable
By Species
Browse the full “Newcastle Disease Vaccine Market By Vaccine Type (Live Attenuated, Inactivated, Thermostable), By Species (Chicken, Duck, Goose, And Others), and By Region: Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts, 2023 – 2030”– Report at https://www.zionmarketresearch.com/report/newcastle-disease-vaccine-market
Competitive Landscape
Some of the main competitors dominating the global Newcastle Disease Vaccine market include –
- Merial
- QYH Biotech
- CEVA
- Yebio
- Ringpu (Tianjin) Bio-Pharmacy Co. Ltd
- Bayer AG
- Hipra, Anicon Labor GmbH
- Chengdu Tech-bank Biological Products Co. Ltd.
- Ringpu Bio-Technology Co. Ltd.
- MSD Animal Health
- Nisseiken Co.
- Harbin Veterinary Research Institute
- Merck Animal Health
- ChengDu Tecbond
- DHN
- Zoetis
- Elanco (Lohmann)
- CAVAC
- Vaksindo
- FATRO
Key Insights from Primary Research:
- As per the analysis shared by our research analyst, the global Newcastle disease vaccine market is expected to grow annually at a promising CAGR of around 4.3% during the forecast period 2023-2030.
- In terms of revenue, the global Newcastle disease vaccine market size was valued at around USD 343.9 million in 2022 and is expected to reach USD 462.6 million by 2030.
- Newcastle Disease Vaccine is a preventative measure used to control the spread of the highly contagious Newcastle disease in poultry. The disease is caused by a paramyxovirus and affects a wide range of domestic and wild bird species, including chickens, turkeys, pigeons, and ducks. The vaccine is formulated to protect against several strains of the Newcastle disease virus.
- Based on vaccine type, the live attenuated segment held the dominating market share in 2022.
- Based on species, the chicken segment held the largest market share in 2022.
- Based on region, the North American region held the dominating market share in 2022.
Have Any Query? Ask Our Experts: https://www.zionmarketresearch.com/inquiry/newcastle-disease-vaccine-market
Key questions answered in this report:
- What is the market size and growth rate forecast for Newcastle Disease Vaccine industry?
- What are the main driving factors propelling the Newcastle Disease Vaccine Market forward?
- What are the leading companies in the Newcastle Disease Vaccine Industry?
- What segments does the Newcastle Disease Vaccine Market cover?
- How can I receive a free copy of the Newcastle Disease Vaccine Market sample report and company profiles?
Key Offerings:
- Market Size & Forecast by Revenue | 2023−2030
- Market Dynamics – Leading Trends, Growth Drivers, Restraints, and Investment Opportunities
- Market Segmentation – A detailed analysis By Vaccine Type, By Species, And By Region
- Competitive Landscape – Top Key Vendors and Other Prominent Vendors
Request for Customization on this Report as per your requirements – https://www.zionmarketresearch.com/custom/5627
(We tailor your report to meet your specific research requirements. Inquire with our sales team about customising your report.)
Regional Analysis:
The North American region held the dominating market share in 2022 and is further predicted to grow rapidly at a notable CAGR during the forecast period. This is mainly due to the increasing demand for poultry products in the region which has led to a rise in the number of poultry farms, thereby increasing the risk of disease outbreaks. In addition, the growing awareness among farmers about the benefits of vaccination programs and the need for effective measures to control the spread of the disease has driven the regional Newcastle disease vaccine market growth. Furthermore, government initiatives to control the spread of Newcastle Disease have been instrumental in promoting the adoption of vaccines among poultry farmers, thereby boosting the market growth.
By Region
- North America
- U.S.
- Canada
- Rest of North America
- Europe
- France
- UK
- Spain
- Germany
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Rest of Asia Pacific
- The Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of the Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Recent Developments
- In 2021, Elanco Animal Health, an American Pharmaceutical company announced that it had completed the acquisition of Kindred Biosciences, a biopharmaceutical company focused on developing vaccines for pets and livestock. The acquisition included Kindred’s Newcastle Disease Virus Vectored vaccine platform, which uses a viral vector to deliver antigens to animals and trigger an immune response. This acquisition will help Elanco to expand its presence in the poultry vaccine market and develop new vaccines for poultry and other animal species.
- In 2020, Merial Animal Health, a multinational animal health company, announced that it had received approval from the European Medicines Agency for a new inactivated vaccine, Vaxxitek® ND-IBD. The vaccine provides protection against both Newcastle Disease and Infectious Bursal Disease in chickens, and its innovative formulation reduces the risk of vaccine reactions.
To know an additional revised 2023 list of market players, request a brochure of the report: https://www.zionmarketresearch.com/requestbrochure/newcastle-disease-vaccine-market
FREQUENTLY ASKED QUESTIONS
What is Newcastle Disease Vaccine?
Newcastle disease is an infectious disease that affects many avian species, both domestic and wild; it is transmissible to humans.
At what CAGR, the global Newcastle disease vaccine market will expand during forecast years?
The global Newcastle disease vaccine market is predicted to increase at a CAGR of 4.3% during the forecast period.
What will be the market value of global Newcastle disease vaccine market by the end of 2030?
The global Newcastle disease vaccine market was worth around USD 343.9 million in 2022 and is expected to reach USD 462.6 million by 2030.
What are the factors driving the global Newcastle disease vaccine market growth?
The global market for Newcastle vaccine disease is driven by the increasing demand for poultry products and the need for effective vaccines to prevent economic losses in the poultry industry. The market growth is also supported by the growing awareness among poultry farmers about the benefits of vaccination programs, advancements in vaccine technology & production methods, and government initiatives to control the spread of the disease.
Which region will contribute notably towards the Newcastle disease vaccine market value?
North America held the largest share in the global Newcastle disease vaccine market in 2022 and is likely to continue the same trend during the forecast period. This is due to factors such as the increasing demand for poultry products, rising investments in animal health research, and government support to control the spread of the disease.
Who are the leading players in global Newcastle disease vaccine market?
Some of the major companies operating in the global Newcastle disease vaccine market include Merial, QYH Biotech, CEVA, Yebio, Ringpu (Tianjin) Bio-Pharmacy Co., Ltd, Bayer AG, Hipra, Anicon Labor GmbH, Chengdu Tech-bank Biological Products Co., Ltd., Ringpu Bio-Technology Co., Ltd., MSD Animal Health, Nisseiken Co., Harbin Veterinary Research Institute, Merck Animal Health, ChengDu Tecbond, DHN, Zoetis, Elanco (Lohmann), CAVAC, Vaksindo, FATRO, and others.
Browse Other Related Research Reports from Zion Market Research:
Therapeutic Vaccines Market By Products (Addiction Vaccines, Autoimmune Disease Vaccines, Infectious Disease Vaccines And Neurological Disease Vaccines) And By Technology (Autologous Vaccine And Allogeneic Vaccine): Global Industry Perspective, Comprehensive Analysis And Forecast,2020 – 2028: https://www.zionmarketresearch.com/report/therapeutic-vaccines-market
Vaccine Delivery Devices Market Size – By Devices (Syringes, Jet Injectors, And Other Devices), By Route Of Administration (Intradermal Vaccination, Intramuscular Vaccination, And Subcutaneous Vaccination), And By Region- – Global Industry Perspective, Comprehensive Analysis, And Forecast, 2020 – 2026: https://www.zionmarketresearch.com/report/vaccine-delivery-devices-market
Vaccine Contract Manufacturing Market – By Workflow (Downstream And Upstream), By Vaccine Type (Attenuated, Subunit, DNA, Inactivated, And Toxoid), By Application (Human And Veterinary), And By Region- Global Industry Perspective, Comprehensive Analysis, And Forecast, 2020 – 2026: https://www.zionmarketresearch.com/report/vaccine-contract-manufacturing-market
Isothermal Boxes for Vaccines Market -by Product Type (Long Range and Short Range), by Application (Research Institute, Bioengineering Laboratory, Medical and Others), and by Region – Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 – 2026: https://www.zionmarketresearch.com/report/isothermal-boxes-vaccines-market
Vaccine Storage & Packaging Market By Function (Storage [Storage Equipment, Service]; Packaging [Packaging Material, Packaging Level]) By End-User (Hospitals, Biopharmaceutical Companies, Medical Laboratories, Others): Global Industry Perspective, Comprehensive Analysis And Forecast, 2020 – 2026: https://www.zionmarketresearch.com/report/vaccine-storage-packaging-market
Veterinary Vaccine Market by Application (Livestock Vaccines and Companion Vaccines), by Technology Types (Attenuated Vaccines, DNA Vaccines, Inactivated Vaccines, Toxoid Vaccines and Recombinant Vaccines) – Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021: https://www.zionmarketresearch.com/report/veterinary-vaccine-market
Recombinant Vaccines Market By Product (Attenuated, Vector, and Subunit), By Application (Veterinary and Human), By Disease (Hepatitis B, Cancer, Influenza, and Others), and By Distribution Channel (Hospitals, Clinics, Veterinary Clinics, Retail Pharmacies, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025: https://www.zionmarketresearch.com/report/recombinant-vaccines-market
Animal Vaccines Market: Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2026: https://www.zionmarketresearch.com/report/animal-vaccines-market
Newcastle Disease Vaccine Market By Vaccine Type (Live Attenuated, Inactivated, Thermostable), By Species (Chicken, Duck, Goose And Others): Global Industry Perspective, Comprehensive Analysis And Forecast, 2020 – 2026: https://www.zionmarketresearch.com/report/newcastle-disease-vaccine-market
H1N1 Vaccines Market – By Route Of Administration (Intradermal Vaccines, Intranasal Vaccines, And Intramuscular Vaccines), And By Region – Global Industry Perspective, Comprehensive Analysis, And Forecast, 2019 – 2025: https://www.zionmarketresearch.com/report/h1n1-vaccines-market
About Zion Market Research:
Zion Market Research is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Zion Market Research are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds.
Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Follow Us on LinkedIn: https://www.linkedin.com/company/zion-market-research/
Follow Us on Twitter: https://twitter.com/zion_research
Follow Us on Facebook: https://www.facebook.com/zionmarketresearch
Follow Us on Pinterest: https://www.pinterest.com/zionmarketresearch/
Follow Us on YouTube: https://youtu.be/Y0Yfi7N8zSs
Contact Us:
Rushikesh Dorge
USA: +1 347 690-0211
United Kingdom: +44 2032 894158
Japan: +81 50 5806 9039
India: +91 7768 006 007
Web: https://www.zionmarketresearch.com/
Blog: https://zmrblog.com/
Still, Looking for More Information? OR Want Data for Inclusion in Magazine, Case Study, or Media?
Email Directly Here with Detail Information: [email protected]
Stay connected with us on social media platform for instant update click here to join our Twitter, & Facebook
We are now on Telegram. Click here to join our channel (@TechiUpdate) and stay updated with the latest Technology headlines.
For all the latest Health News Click Here
For the latest news and updates, follow us on Google News.